These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18618158)

  • 1. Guidelines for completing the EURONHEED transferability information checklists.
    Nixon J; Rice S; Drummond M; Boulenger S; Ulmann P; de Pouvourville G
    Eur J Health Econ; 2009 May; 10(2):157-65. PubMed ID: 18618158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can economic evaluations be made more transferable?
    Boulenger S; Nixon J; Drummond M; Ulmann P; Rice S; de Pouvourville G
    Eur J Health Econ; 2005 Dec; 6(4):334-46. PubMed ID: 16249933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a scoring system to quality assess economic evaluations.
    Gonzalez-Perez JG
    Eur J Health Econ; 2002; 3(2):131-6. PubMed ID: 15609137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic analysis of treatment of functional dyspepsia. An assessment of the quality of published studies.
    García-Altés A; Jovell E
    Int J Technol Assess Health Care; 2001; 17(4):517-27. PubMed ID: 11758296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diffusion of health economics knowledge in Europe : The EURONHEED (European Network of Health Economics Evaluation Database) project.
    de Pouvourville G; Ulmann P; Nixon J; Boulenger S; Glanville J; Drummond M
    Pharmacoeconomics; 2005; 23(2):113-20. PubMed ID: 15748086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of the Content and Consistency of Methodological Quality and Transferability Checklists for Reviewing Model-Based Economic Evaluations.
    Lim KK; Koleva-Kolarova R; Fox-Rushby J
    Pharmacoeconomics; 2022 Oct; 40(10):989-1003. PubMed ID: 35907179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
    Krauth C; John J; Aidelsburger P; Brüggenjürgen B; Hansmeier T; Hessel F; Kohlmann T; Moock J; Rothgang H; Schweikert B; Seitz R; Wasem J;
    Gesundheitswesen; 2008 Jun; 70(6):e1-16. PubMed ID: 18661452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review.
    Berg ML; Cheung KL; Hiligsmann M; Evers S; de Kinderen RJA; Kulchaitanaroaj P; Pokhrel S
    Addiction; 2017 Jun; 112(6):946-967. PubMed ID: 28060453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaching standards for dissemination: a case study.
    Christensen H; Griffiths K
    Stud Health Technol Inform; 2007; 129(Pt 1):459-63. PubMed ID: 17911759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines.
    Simoens S
    Curr Med Res Opin; 2009 Oct; 25(10):2447-57. PubMed ID: 19678752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Gunnar Aus, Christopher Chapple, Tomas Hanûs, et al. The European Association of Urology (EAU) guidelines methodology: a critical evaluation. Eur Urol 2009;56:859-64.
    Dahm P; Yeung L; Schünemann H
    Eur Urol; 2009 Nov; 56(5):e21-2. PubMed ID: 19028007
    [No Abstract]   [Full Text] [Related]  

  • 14. The European Network of Health Economic Evaluation Databases (EURO NHEED) Project.
    Nixon J; Ulmann P; Glanville J; Boulenger S; Drummond M; de Pouvourville G
    Eur J Health Econ; 2004 Jun; 5(2):183-7. PubMed ID: 15452755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferability indices for health economic evaluations: methods and applications.
    Antonanzas F; Rodríguez-Ibeas R; Juárez C; Hutter F; Lorente R; Pinillos M
    Health Econ; 2009 Jun; 18(6):629-43. PubMed ID: 18677724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Checklists for external validity: a systematic review.
    Dyrvig AK; Kidholm K; Gerke O; Vondeling H
    J Eval Clin Pract; 2014 Dec; 20(6):857-64. PubMed ID: 24828521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In search of the evidentiary foundation of published Canadian economic evaluations (2001-06).
    Tarride JE; Lim ME; Bowen JM; McCarron CE; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
    Int J Technol Assess Health Care; 2009 Apr; 25(2):214-21. PubMed ID: 19331712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data briefing. Evidence-based choice.
    Appleby J
    Health Serv J; 2004 May; 114(5907):27. PubMed ID: 15188728
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic evaluation databases as an aid to healthcare decision makers and researchers.
    Aguiar-Ibáñez R; Nixon J; Glanville J; Craig D; Rice S; Christie J; Drummond MF
    Expert Rev Pharmacoecon Outcomes Res; 2005 Dec; 5(6):721-32. PubMed ID: 19807614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.